A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase…

Overview of attention for article published in BMC Infectious Diseases, July 2020

Altmetric Badge

Citations

dimensions_citation: 6 Dimensions

Readers on

mendeley: 56 Mendeley

Summary Dimensions citations

So far, Dimensions has found 6 publications that cite this research output.

6

The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.

Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48–96 weeks of RETROBIC Study

Article in Journal of Antimicrobial Chemotherapy (January 2024)

HOPX Plays a Critical Role in Antiretroviral Drugs Induced Epigenetic Modification and Cardiac Hypertrophy

Article in Cells (December 2021)

Clinical Safety Considerations of Integrase Strand Transfer Inhibitors in the Older Population Living with HIV

Article in Drugs & Aging (September 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.